Concepedia

Nicolas Béry

NB

18

Publications

1.3K

Citations

15

H-Index

2011

Active since

Affiliations

University of Oxford(Current)

Inserm

John Radcliffe Hospital

Centre National de la Recherche Scientifique

Centre de Recherche en Cancérologie de Toulouse

Nicolas Béry is an author at University of Oxford specializing in medicine, natural sciences, and cell biology.

ORCID

Top concepts

Publications per year

2011–2024

18

Publications

18

NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies

Sandrine Moutel, Nicolas Béry, Virginie Bernard et al. · eLife · 2016 · 314 citations · Full text

, , +20

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds

Abimael Cruz-Migoni, Peter Canning, Camilo Quevedo et al. · Proceedings of the National Academy of Sciences · 2019 · 137 citations · Full text

Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment

Camilo Quevedo, Abimael Cruz-Migoni, Nicolas Béry et al. · Nature Communications · 2018 · 130 citations · Full text

A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS

Nicolas Béry, Ami Miller · Nature Communications · 2020 · 126 citations · Full text

Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange

Sandrine Guillard, Paulina Kolasinska-Zwierz, J.E. Debreczeni et al. · Nature Communications · 2017 · 105 citations · Full text

Rows per page

1–5 of 18